By Tamara MathiasAug 10 (Reuters) - Alnylam Pharmaceuticals Inc's drug for a rare hereditary disease won U.S. regulatory approval on Friday, becoming the...


50


Daily Mail

11 Related Articles, between 2018-08-10 and 2018-08-08